MeSH tree: E05.200.998
By analyzing heart rhythm recordings and blood tests, artificial intelligence may accurately flag when a transplant patient's body starts attacking a donated heart, a new study suggests.
Oct 6, 2026
0
5
Understanding how fetal DNA travels in a pregnant woman's blood could unlock the next generation of prenatal screening, according to a new paper published in Science Advances.
Oct 2, 2026
0
10
A real-world study of 8,391 patients found that autonomous artificial intelligence (AI) could free up enough clinical capacity to provide more than 8,500 additional face-to-face dermatology appointments across two U.K. hospitals ...
Sep 30, 2026
0
8
Skin cancer is the most common cancer in the United States and among the most common worldwide. Nearly 1.5 million new cases were diagnosed globally in 2024, including nearly 340,000 melanomas. Nonmelanoma skin cancers—primarily ...
Sep 30, 2026
0
8
In a study published in Cancer Discovery, cancer neoantigens and neoantigen-specific T cells were identified from patient blood samples by analyzing circulating tumor DNA (ctDNA) and immune cells.
Sep 29, 2026
0
13
Most of us are used to hearing about the risks of not getting enough iron. Yet having too much iron in the body can also cause serious health problems.
Sep 15, 2026
0
10
As more individuals with cerebral palsy live well into adulthood, medical professionals are taking a closer look at the unique long-term health care needs of this patient population. While adults with cerebral palsy require ...
Sep 9, 2026
0
6
The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals' Mimrylo (rusfertide) as a new treatment for adults with polycythemia vera who have not achieved adequate control with existing therapies.
Sep 4, 2026
0
10
A single blood test could in the future provide a more comprehensive picture of cancer than current methods. In a review article published in the journal Genome Medicine, researchers at Karolinska Institutet describe how ...
Aug 11, 2026
0
7
Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy determined that liquid biopsy—a blood test that detects circulating tumor DNA (ctDNA)—can predict, within a ...
Aug 3, 2026
0
5
